We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Gallus Enters Clinical cGMP Manufacturing Agreement with Symphogen

News   Mar 01, 2014

 
Gallus Enters Clinical cGMP Manufacturing Agreement with Symphogen
 
 
 

RELATED ARTICLES

Protein "Spat Out" by Cancer Cells Promotes Tumor Growth

News

Prostate cancer cells change the behavior of other cells around them, including normal cells, by 'spitting out' a protein from their nucleus.

READ MORE

Peptide May Protect Kidneys From Ourselves

News

A synthetic peptide appears to directly disrupt the destructive inflammation that occurs in nephritis, enabling the kidneys to better recover and maintain their important functions.

READ MORE

Twin Registry Used to Reveal Autoimmune Drivers

News

Data from the world’s largest twin registry shows that the risk of developing seven autoimmune diseases is largely inherited, but that some diseases are more closely related than others.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE